首页> 外文学位 >Alterations in cytoskeletal proteins in the failing human myocardium.
【24h】

Alterations in cytoskeletal proteins in the failing human myocardium.

机译:衰竭人心肌中细胞骨架蛋白的变化。

获取原文
获取原文并翻译 | 示例

摘要

Cardiac hypertrophy, a compensatory mechanism, is characterized by enlargement of individual cardiac myocytes. The enlargement, which does not compromise ventricular function, occurs in response to increased workload. The heart progresses into a stage known as heart failure. In this stage of heart failure ventricular function is severely compromised. In some patients who require a heart transplant for end stage heart failure, a left ventricular assist device (LVAD) is implanted into the heart to mechanically unload the left ventricle.; Two factors which contribute to contractile dysfunction in the failing heart include impaired calcium cycling via excitation-contraction coupling and decreased β-adrenergic responsiveness. In addition, structural alterations such as increased cell size and increased fibrosis may occur and contribute to decreased contractile function. Alterations in the cytoskeleton, a network of proteins which maintains the structure of the cardiac myocyte, may also play a role in heart failure.; Quantitation of cytoskeletal proteins by Western blot analysis was used to test the hypothesis that the cytoskeletal proteins, α-actinin, vinculin, desmin and β-tubulin, are altered in human heart failure and to a lesser degree in cardiac hypertrophy. The localization of these proteins was examined in isolated human cardiac myocytes from nonfailing, hypertrophied and failing hearts by immunofluorescence using confocal microscopy. Similarly, the effects of reversibility by mechanical unloading with an LVAD were also tested. The effect of depolymerization and hyperpolymerization of β-tubulin on the β-adrenergic response was also tested using muscles from failing hearts.; There were no significant differences in α-actinin, vinculin and β-tubulin protein in hypertrophied and failing hearts as compared to nonfailing hearts. However, there was a significant increase in desmin protein. Immunofluorescence revealed alterations in the localization of vinculin, desmin and β-tubulin in hypertrophied and failing cardiac myocytes. The functional effect of increased β-tubulin polymerization on the β-adrenergic response was negligible. This study has shown that cytoskeletal proteins, although not quantitatively altered, are qualitatively changed in the hypertrophied and failing human heart. Functional implications of these changes remain to be clarified.
机译:心脏肥大是一种补偿机制,其特征在于单个心肌细胞的增大。响应于增加的工作量而发生了不损害心室功能的增大。心脏进入称为心力衰竭的阶段。在心力衰竭的这一阶段,心室功能严重受损。在某些需要进行心脏移植以治疗晚期心力衰竭的患者中,将左心室辅助装置(LVAD)植入心脏以机械卸载左心室。导致衰竭心脏收缩功能障碍的两个因素包括通过兴奋-收缩偶联引起的钙循环受损和β-肾上腺素反应性降低。另外,可能发生结构改变,例如细胞大小增加和纤维化增加,并导致收缩功能降低。维持心脏心肌细胞结构的蛋白质网络-细胞骨架的改变,也可能在心力衰竭中起作用。通过蛋白质印迹分析定量细胞骨架蛋白被用于检验以下假设:在人类心力衰竭中,细胞骨架蛋白,α-肌动蛋白,纽蛋白,结蛋白和β-微管蛋白发生改变,而在心脏肥大中发生程度较小。使用共聚焦显微镜通过免疫荧光检测了这些蛋白质在未分离,肥大和衰竭心脏的分离的人心肌细胞中的定位。同样,还测试了通过LVAD机械卸载产生的可逆性影响。还使用来自心脏衰竭的肌肉测试了β-微管蛋白的解聚和超聚对β-肾上腺素能反应的影响。肥厚和衰竭的心脏与未衰竭的心脏相比,α-肌动蛋白,纽蛋白和β-微管蛋白没有显着差异。然而,结蛋白的蛋白质显着增加。免疫荧光显示肥大和衰竭的心肌细胞中长春花素,结蛋白和β-微管蛋白的定位发生改变。增强的β-微管蛋白聚合对β-肾上腺素反应的功能影响可以忽略不计。这项研究表明,在肥大和衰竭的人心脏中,细胞骨架蛋白虽然没有定量改变,但在质上却发生了变化。这些更改的功能含义仍有待阐明。

著录项

  • 作者单位

    Cleveland State University.;

  • 授予单位 Cleveland State University.;
  • 学科 Biology Cell.; Health Sciences Medicine and Surgery.; Biology Animal Physiology.
  • 学位 Ph.D.
  • 年度 2003
  • 页码 166 p.
  • 总页数 166
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 细胞生物学;生理学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号